Medicaid reimbursement for immediate post-abortion provision of long-acting reversible contraception reduces both unintended pregnancies and health care expenditures

Contraception. 2014 Dec;90(6):616-7. doi: 10.1016/j.contraception.2014.05.020. Epub 2014 Jun 26.

Authors

Tsu-Yu Tsao¹, Cristina Yunzal-Butler², Judith Sackoff², Deborah Kaplan²

Affiliations

¹ Bureau of Epidemiology Services, New York City Department of Health and Mental Hygiene. Electronic address: [email protected].
² Bureau of Maternal, Infant and Reproductive Health, New York City Department of Health and Mental Hygiene.

PMID: 25108581
DOI: 10.1016/j.contraception.2014.05.020

No abstract available

Keywords: Contraceptives; Cost savings; IUD; Reproductive health access.

Publication types

Letter
Research Support, U.S. Gov't, P.H.S.
Comment

MeSH terms

Abortion, Induced*
Contraceptive Agents, Female / administration & dosage*
Female
Humans
Intrauterine Devices*
Medroxyprogesterone Acetate / administration & dosage*
Pregnancy
Pregnancy, Unwanted*

Substances

Contraceptive Agents, Female
Medroxyprogesterone Acetate

Grants and funding

5U58CD0001252-04/CD/ODCDC CDC HHS/United States